Improving breast cancer therapy with CDK4/6 inhibitors

Clin Breast Cancer. 2014 Dec;14(6):379-80. doi: 10.1016/j.clbc.2014.10.001. Epub 2014 Oct 13.

Authors

Hamsa Jaganathan¹, Karen Overstreet², Elizabeth Reed³

Affiliations

¹ Medical Affairs, Imedex, LLC, Alpharetta, GA. Electronic address: h.jaganathan@imedex.com.
² Medical Affairs, Imedex, LLC, Alpharetta, GA.
³ Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE.

PMID: 25457990
DOI: 10.1016/j.clbc.2014.10.001

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Breast Neoplasms / drug therapy*
Breast Neoplasms / enzymology
Cyclin-Dependent Kinase 4 / antagonists & inhibitors*
Cyclin-Dependent Kinase 6 / antagonists & inhibitors*
Female
Humans
Protein Kinase Inhibitors / therapeutic use*

Substances

Protein Kinase Inhibitors
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6